LOCUS       NM_000024               2058 bp    mRNA    linear   PRI 02-JAN-2020
DEFINITION  Homo sapiens adrenoceptor beta 2 (ADRB2), mRNA.
ACCESSION   NM_000024
VERSION     NM_000024.5
KEYWORDS    RefSeq; RefSeq Select.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2058)
  AUTHORS   Wang L, Lv Q, Song X, Jiang K and Zhang J.
  TITLE     ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory
            cytokine regulated by miR-15a-5p
  JOURNAL   Hum. Cell 32 (3), 306-315 (2019)
   PUBMED   31104300
  REMARK    GeneRIF: ADRB2 is negatively regulated by miR-15a-5p, which
            inhibits IL-13-induced nasal epithelial inflammatory responses.
REFERENCE   2  (bases 1 to 2058)
  AUTHORS   Agarwal SR, Fiore C, Miyashiro K, Ostrom RS and Harvey RD.
  TITLE     Effect of Adenylyl Cyclase Type 6 on Localized Production of cAMP
            by beta-2 Adrenoceptors in Human Airway Smooth-Muscle Cells
  JOURNAL   J. Pharmacol. Exp. Ther. 370 (1), 104-110 (2019)
   PUBMED   31068382
  REMARK    GeneRIF: Effect of Adenylyl Cyclase Type 6 on Localized Production
            of cAMP by beta-2 Adrenoceptors in Human Airway Smooth-Muscle Cells
REFERENCE   3  (bases 1 to 2058)
  AUTHORS   Zhang YQ and Zhu KR.
  TITLE     The C79G Polymorphism of the beta2-Adrenergic Receptor Gene, ADRB2,
            and Susceptibility to Pediatric Asthma: Meta-Analysis from Review
            of the Literature
  JOURNAL   Med. Sci. Monit. 25, 4005-4013 (2019)
   PUBMED   31142730
  REMARK    GeneRIF: Expression of the C79G polymorphism of the ADRB2 gene was
            significantly associated with risk of pediatric asthma associated
            with the C or G allele with comparison of the co-dominant model (GG
            vs. CC: OR, 0.69; 95% CI, 0.55-0.88) and the recessive model (GG
            vs. CC+CG: OR, 0.65; 95% CI, 0.53-0.81). The C79G polymorphism was
            associated with a reduced risk for the development of pediatric
            asthma.
            Review article
            Publication Status: Online-Only
REFERENCE   4  (bases 1 to 2058)
  AUTHORS   Wang T, Xing Y, Meng Q, Lu H, Liu W, Yan S, Song Y, Xu X, Huang J,
            Cui Y, Jia D and Cai L.
  TITLE     Mammalian Eps15 homology domain 1 potentiates angiogenesis of
            non-small cell lung cancer by regulating beta2AR signaling
  JOURNAL   J. Exp. Clin. Cancer Res. 38 (1), 174 (2019)
   PUBMED   31023336
  REMARK    GeneRIF: the data obtained in this study suggest that EHD1 plays a
            critical role in Non-small cell lung cancer (NSCLC) angiogenesis
            via b2AR signaling and highlight a potential target for
            antiangiogenic therapy.
            Publication Status: Online-Only
REFERENCE   5  (bases 1 to 2058)
  AUTHORS   Parola AL and Kobilka BK.
  TITLE     The peptide product of a 5' leader cistron in the beta 2 adrenergic
            receptor mRNA inhibits receptor synthesis
  JOURNAL   J. Biol. Chem. 269 (6), 4497-4505 (1994)
   PUBMED   8308019
REFERENCE   6  (bases 1 to 2058)
  AUTHORS   Gope R, Gope ML, Thorson A, Christensen M, Smyrk T, Chun M, Alvarez
            L, Wildrick DM and Boman BM.
  TITLE     Genetic changes at the beta-2-adrenergic receptor locus on
            chromosome 5 in human colorectal carcinomas
  JOURNAL   Anticancer Res. 11 (6), 2047-2050 (1991)
   PUBMED   1663718
REFERENCE   7  (bases 1 to 2058)
  AUTHORS   Bouvier M, Guilbault N and Bonin H.
  TITLE     Phorbol-ester-induced phosphorylation of the beta 2-adrenergic
            receptor decreases its coupling to Gs
  JOURNAL   FEBS Lett. 279 (2), 243-248 (1991)
   PUBMED   1848190
REFERENCE   8  (bases 1 to 2058)
  AUTHORS   Yang-Feng TL, Xue FY, Zhong WW, Cotecchia S, Frielle T, Caron MG,
            Lefkowitz RJ and Francke U.
  TITLE     Chromosomal organization of adrenergic receptor genes
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 87 (4), 1516-1520 (1990)
   PUBMED   2154750
REFERENCE   9  (bases 1 to 2058)
  AUTHORS   Emorine LJ, Marullo S, Delavier-Klutchko C, Kaveri SV,
            Durieu-Trautmann O and Strosberg AD.
  TITLE     Structure of the gene for human beta 2-adrenergic receptor:
            expression and promoter characterization
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 84 (20), 6995-6999 (1987)
   PUBMED   2823249
REFERENCE   10 (bases 1 to 2058)
  AUTHORS   Bucens,D. and Pain,M.C.
  TITLE     Influence of hematocrit, blood gas tensions, and pH on
            pressure-flow relations in the isolated canine lung
  JOURNAL   Circ. Res. 37 (5), 588-596 (1975)
   PUBMED   154
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DA705141.1, BC073856.1,
            M15169.1, BC012481.2 and AA886615.1.
            This sequence is a reference standard in the RefSeqGene project.
            
            [WARNING] On Jan 15, 2020 this sequence was replaced by
            NM_000024.6.
            
            On Jan 8, 2010 this sequence version replaced NM_000024.4.
            
            Summary: This gene encodes beta-2-adrenergic receptor which is a
            member of the G protein-coupled receptor superfamily. This receptor
            is directly associated with one of its ultimate effectors, the
            class C L-type calcium channel Ca(V)1.2. This receptor-channel
            complex also contains a G protein, an adenylyl cyclase,
            cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A.
            The assembly of the signaling complex provides a mechanism that
            ensures specific and rapid signaling by this G protein-coupled
            receptor. This receptor is also a transcription regulator of the
            alpha-synuclein gene, and together, both genes are believed to be
            associated with risk of Parkinson's Disease. This gene is
            intronless. Different polymorphic forms, point mutations, and/or
            downregulation of this gene are associated with nocturnal asthma,
            obesity, type 2 diabetes and cardiovascular disease. [provided by
            RefSeq, Oct 2019].
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##RefSeq-Attributes-START##
            RefSeq Select criteria :: based on single protein-coding transcript
            regulatory uORF        :: PMID: 8308019
            ##RefSeq-Attributes-END##
            COMPLETENESS: full length.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-101               DA705141.1         349-449
            102-284             BC073856.1         53-235
            285-1515            M15169.1           1633-2863
            1516-2033           BC012481.2         1488-2005
            2034-2058           AA886615.1         242-266
FEATURES             Location/Qualifiers
     source          1..2058
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="5"
                     /map="5q32"
     gene            1..2058
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="adrenoceptor beta 2"
                     /db_xref="GeneID:154"
                     /db_xref="HGNC:HGNC:286"
                     /db_xref="MIM:109690"
     exon            1..2042
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    6..8
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="upstream in-frame stop codon"
     misc_feature    21
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="alternative transcription initiation site"
     misc_feature    28
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="alternative transcription initiation site"
     misc_feature    31
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="alternative transcription initiation site"
     misc_feature    40
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="alternative transcription initiation site"
     regulatory      139..198
                     /regulatory_class="other"
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="DESCRIPTION:regulatory uORF[PMID:8308019]"
                     /note="regulatory uORF; this uORF encodes a 19 aa peptide
                     (PMID:8308019)"
     CDS             240..1481
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /note="catecholamine receptor; beta-2 adrenoceptor; beta-2
                     adrenoreceptor; adrenergic, beta-2-, receptor, surface;
                     adrenoceptor beta 2 surface"
                     /codon_start=1
                     /product="beta-2 adrenergic receptor"
                     /protein_id="NP_000015.1"
                     /db_xref="CCDS:CCDS4292.1"
                     /db_xref="GeneID:154"
                     /db_xref="HGNC:HGNC:286"
                     /db_xref="MIM:109690"
                     /translation="MGQPGNGSAFLLAPNRSHAPDHDVTQQRDEVWVVGMGIVMSLIV
                     LAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFG
                     NFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIV
                     SGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFV
                     YSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLG
                     IIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRI
                     AFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQG
                     TVPSDNIDSQGRNCSTNDSLL"
     misc_feature    255..257
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N-linked (GlcNAc...) asparagine. {ECO:0000305};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     glycosylation site"
     misc_feature    282..284
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="N-linked (GlcNAc...) asparagine. {ECO:0000305};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     glycosylation site"
     misc_feature    342..413
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    453..524
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    558..626
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    660..662
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphotyrosine. {ECO:0000269|PubMed:8521811};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     phosphorylation site"
     misc_feature    690..761
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    816..860
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     Region: Agonist and antagonist binding"
     misc_feature    828..899
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    975..977
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:17525332};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     phosphorylation site"
     misc_feature    1020..1022
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by PKA. {ECO:0000255}; propagated
                     from UniProtKB/Swiss-Prot (P07550.3); phosphorylation
                     site"
     misc_feature    1023..1025
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by PKA. {ECO:0000255}; propagated
                     from UniProtKB/Swiss-Prot (P07550.3); phosphorylation
                     site"
     misc_feature    1062..1133
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    1095..1118
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     Region: Agonist and antagonist binding"
     misc_feature    1155..1226
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     transmembrane region"
     misc_feature    1173..1187
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     Region: Agonist and antagonist binding"
     misc_feature    1272..1274
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by PKA.
                     {ECO:0000269|PubMed:11146000}; propagated from
                     UniProtKB/Swiss-Prot (P07550.3); phosphorylation site"
     misc_feature    1275..1277
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by PKA.
                     {ECO:0000269|PubMed:11146000}; propagated from
                     UniProtKB/Swiss-Prot (P07550.3); phosphorylation site"
     misc_feature    1302..1304
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by BARK. {ECO:0000305}; propagated
                     from UniProtKB/Swiss-Prot (P07550.3); phosphorylation
                     site"
     misc_feature    1305..1307
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine, by BARK. {ECO:0000305}; propagated
                     from UniProtKB/Swiss-Prot (P07550.3); phosphorylation
                     site"
     misc_feature    1383..1385
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="4-hydroxyproline. {ECO:0000269|PubMed:19584355};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     hydroxylation site"
     misc_feature    1422..1424
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="4-hydroxyproline. {ECO:0000269|PubMed:19584355};
                     propagated from UniProtKB/Swiss-Prot (P07550.3);
                     hydroxylation site"
     misc_feature    1467..1478
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P07550.3);
                     Region: PDZ-binding"
     regulatory      1551..1556
                     /regulatory_class="polyA_signal_sequence"
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
     polyA_site      1571
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
     regulatory      2013..2018
                     /regulatory_class="polyA_signal_sequence"
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
     polyA_site      2042
                     /gene="ADRB2"
                     /gene_synonym="ADRB2R; ADRBR; B2AR; BAR; BETA2AR"
ORIGIN      
        1 gcacataacg ggcagaacgc actgcgaagc ggcttcttca gagcacgggc tggaactggc
       61 aggcaccgcg agcccctagc acccgacaag ctgagtgtgc aggacgagtc cccaccacac
      121 ccacaccaca gccgctgaat gaggcttcca ggcgtccgct cgcggcccgc agagccccgc
      181 cgtgggtccg cccgctgagg cgcccccagc cagtgcgctc acctgccaga ctgcgcgcca
      241 tggggcaacc cgggaacggc agcgccttct tgctggcacc caatagaagc catgcgccgg
      301 accacgacgt cacgcagcaa agggacgagg tgtgggtggt gggcatgggc atcgtcatgt
      361 ctctcatcgt cctggccatc gtgtttggca atgtgctggt catcacagcc attgccaagt
      421 tcgagcgtct gcagacggtc accaactact tcatcacttc actggcctgt gctgatctgg
      481 tcatgggcct ggcagtggtg ccctttgggg ccgcccatat tcttatgaaa atgtggactt
      541 ttggcaactt ctggtgcgag ttttggactt ccattgatgt gctgtgcgtc acggccagca
      601 ttgagaccct gtgcgtgatc gcagtggatc gctactttgc cattacttca cctttcaagt
      661 accagagcct gctgaccaag aataaggccc gggtgatcat tctgatggtg tggattgtgt
      721 caggccttac ctccttcttg cccattcaga tgcactggta ccgggccacc caccaggaag
      781 ccatcaactg ctatgccaat gagacctgct gtgacttctt cacgaaccaa gcctatgcca
      841 ttgcctcttc catcgtgtcc ttctacgttc ccctggtgat catggtcttc gtctactcca
      901 gggtctttca ggaggccaaa aggcagctcc agaagattga caaatctgag ggccgcttcc
      961 atgtccagaa ccttagccag gtggagcagg atgggcggac ggggcatgga ctccgcagat
     1021 cttccaagtt ctgcttgaag gagcacaaag ccctcaagac gttaggcatc atcatgggca
     1081 ctttcaccct ctgctggctg cccttcttca tcgttaacat tgtgcatgtg atccaggata
     1141 acctcatccg taaggaagtt tacatcctcc taaattggat aggctatgtc aattctggtt
     1201 tcaatcccct tatctactgc cggagcccag atttcaggat tgccttccag gagcttctgt
     1261 gcctgcgcag gtcttctttg aaggcctatg ggaatggcta ctccagcaac ggcaacacag
     1321 gggagcagag tggatatcac gtggaacagg agaaagaaaa taaactgctg tgtgaagacc
     1381 tcccaggcac ggaagacttt gtgggccatc aaggtactgt gcctagcgat aacattgatt
     1441 cacaagggag gaattgtagt acaaatgact cactgctgta aagcagtttt tctactttta
     1501 aagacccccc cccccaacag aacactaaac agactattta acttgagggt aataaactta
     1561 gaataaaatt gtaaaattgt atagagatat gcagaaggaa gggcatcctt ctgccttttt
     1621 tattttttta agctgtaaaa agagagaaaa cttatttgag tgattatttg ttatttgtac
     1681 agttcagttc ctctttgcat ggaatttgta agtttatgtc taaagagctt tagtcctaga
     1741 ggacctgagt ctgctatatt ttcatgactt ttccatgtat ctacctcact attcaagtat
     1801 taggggtaat atattgctgc tggtaatttg tatctgaagg agattttcct tcctacaccc
     1861 ttggacttga ggattttgag tatctcggac ctttcagctg tgaacatgga ctcttccccc
     1921 actcctctta tttgctcaca cggggtattt taggcaggga tttgaggagc agcttcagtt
     1981 gttttcccga gcaaagtcta aagtttacag taaataaatt gtttgaccat gccttcattg
     2041 caaaaaaaaa aaaaaaaa
//
